1. Home
  2. WINT vs OST Comparison

WINT vs OST Comparison

Compare WINT & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WINT
  • OST
  • Stock Information
  • Founded
  • WINT 1992
  • OST 2010
  • Country
  • WINT United States
  • OST China
  • Employees
  • WINT N/A
  • OST N/A
  • Industry
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • OST Industrial Machinery/Components
  • Sector
  • WINT Health Care
  • OST Technology
  • Exchange
  • WINT Nasdaq
  • OST Nasdaq
  • Market Cap
  • WINT 2.9M
  • OST 3.1M
  • IPO Year
  • WINT 1995
  • OST 2022
  • Fundamental
  • Price
  • WINT $0.31
  • OST $0.16
  • Analyst Decision
  • WINT Hold
  • OST
  • Analyst Count
  • WINT 1
  • OST 0
  • Target Price
  • WINT $7.00
  • OST N/A
  • AVG Volume (30 Days)
  • WINT 1.2M
  • OST 476.7K
  • Earning Date
  • WINT 11-27-2024
  • OST 01-29-2025
  • Dividend Yield
  • WINT N/A
  • OST N/A
  • EPS Growth
  • WINT N/A
  • OST N/A
  • EPS
  • WINT N/A
  • OST N/A
  • Revenue
  • WINT N/A
  • OST $38,203,634.00
  • Revenue This Year
  • WINT N/A
  • OST N/A
  • Revenue Next Year
  • WINT N/A
  • OST N/A
  • P/E Ratio
  • WINT N/A
  • OST N/A
  • Revenue Growth
  • WINT N/A
  • OST N/A
  • 52 Week Low
  • WINT $0.32
  • OST $0.16
  • 52 Week High
  • WINT $14.75
  • OST $0.85
  • Technical
  • Relative Strength Index (RSI)
  • WINT 28.66
  • OST 36.55
  • Support Level
  • WINT $0.33
  • OST $0.16
  • Resistance Level
  • WINT $0.42
  • OST $0.21
  • Average True Range (ATR)
  • WINT 0.03
  • OST 0.02
  • MACD
  • WINT 0.02
  • OST 0.00
  • Stochastic Oscillator
  • WINT 1.91
  • OST 18.94

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: